'Skin Booster' as a Category: What the Umbrella Term Actually Covers
'Skin booster' is a commercial umbrella term for injectable products placed into the upper layers of skin with the aim of changing how hydrated and reflective it looks, rather than adding volume. It covers several chemically unrelated ingredient families, so two clinics using the same word may mean entirely different substances. Evidence quality varies sharply between those families, and only a licensed doctor examining you in person can discuss whether any injectable is appropriate.
The term is commercial, not clinical
On Korean clinic menus you will meet 물광주사 (mulgwang jusa), literally 'water-glow injection', sitting beside the English phrase. Neither is a regulated product class. Both describe an intention — putting something into the dermis so skin looks more hydrated and light-reflective — rather than a defined material with a defined mechanism. That matters practically. If you compare two clinics on the word alone you are comparing marketing copy, not products. The only useful question is which specific licensed product is in the syringe, and clinics should be willing to show you the box.
The families hiding under one word
Broadly, four things get called skin boosters. Stabilised hyaluronic acid preparations designed to sit in skin rather than build contour. Polynucleotide-derived products, marketed heavily in Korea and typically sold as courses. Biostimulatory materials that work slowly by provoking the body's own response over weeks. And cocktails mixed on site from vitamins, amino acids or other ingredients, which is the least standardised end of the category. These differ in regulatory status, in how they behave, and in how much published work exists behind them. Grouping them together flatters the weakest members.
How thin the evidence gets, honestly
Stabilised hyaluronic acid injectables have the most literature behind them, though studies are often small, industry-funded and reliant on photographs and self-reported satisfaction rather than objective measures. Polynucleotide products are the subject of growing but still limited research, much of it from a small number of centres. Compounded on-site cocktails have close to nothing, because a mixture blended in a clinic room cannot easily be studied. Popularity in Korea is not evidence. A category can be simultaneously in enormous demand and under-examined, and this one currently is.
Risks are real and the assessment must be in person
Anything delivered by needle carries bruising, swelling, tenderness, lumps that may take time to settle, and infection risk. Nodules and inflammatory reactions are reported with several injectable families. Rare vascular events are the serious end, which is why the training and setting of whoever holds the syringe matters more than the brand on the menu. Nothing here is a recommendation, and this page deliberately gives no candidacy criteria. If you are curious about injectables, that conversation belongs with a licensed doctor who can examine your skin, review your history and explain what could go wrong.
Try the free tools
✍️ Written & reviewed by the KoreaPlus Editorial team — dermatologist-informed, cosmetic-science researched & source-cited. Last reviewed: 2026-08-23.
General educational information using cosmetic structure-function wording — not medical advice. Always patch-test new actives. © KoreaPlus.